Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

108.39
Delayed Data
As of 12:47pm ET
 -0.35 / -0.32%
Today’s Change
41.99
Today|||52-Week Range
109.95
+103.70%
Year-to-Date

Today’s Trading

Previous close108.74
Today’s open109.21
Day’s range107.82 - 109.71
Volume125,624
Average volume (3 months)396,569
Market cap$2.1B
Dividend yield--
Data as of 12:47pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+87.83%
Earnings growth (next 5 years)+46.08%
Revenue growth (last year)+31.78%
P/E ratio216.0
Price/Sales17.67
Price/Book80.88

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.83-1.40%
MDCOMedicines Co-0.27-0.87%
PRTAProthena Corporation...+0.44+0.65%
FOLDAmicus Therapeutics ...+0.13+0.73%
Data as of 1:02pm ET, 08/04/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.82
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts